Tolmar

Tolmar company information, Employees & Contact Information

Explore related pages

Related company profiles:

Founded in 2007, we are a specialty pharmaceutical company dedicated to innovating treatments in the areas of urology, oncology, and endocrinology. Tolmar is recognized internationally for our advanced long-acting injectable drug delivery capabilities. We are known for being a committed ally to our partners and to the patients and provider communities we serve.

Company Details

Employees
941
Founded
-
Address
701 Centre Ave, Fort Collins,co 80526,united States
Phone
970-212-4500
Email
in****@****mar.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
tolmar.com
HQ
Fort Collins, CO
Looking for a particular Tolmar employee's phone or email?

Tolmar Questions

News

Tolmar Pharmaceuticals Canada Appoints Mike Patterson as General Manager - Yahoo

Tolmar Pharmaceuticals Canada Appoints Mike Patterson as General Manager Yahoo

ZERO Prostate Cancer and Tolmar Launch Groundbreaking "Peaks Challenge" to Spotlight Survivorship and Early Detection - PR Newswire

ZERO Prostate Cancer and Tolmar Launch Groundbreaking "Peaks Challenge" to Spotlight Survivorship and Early Detection PR Newswire

ELIGARD® (Leuprolide Acetate) for Injectable Suspension - GlobeNewswire

ELIGARD® (Leuprolide Acetate) for Injectable Suspension GlobeNewswire

Tolmar Collaborates with Direct-to-Patient Telemedicine Company UpScriptHealth to Increase Access to Oral Testosterone Replacement Therapy - Yahoo Finance

Tolmar Collaborates with Direct-to-Patient Telemedicine Company UpScriptHealth to Increase Access to Oral Testosterone Replacement Therapy Yahoo Finance

Telehealth firm UpScriptHealth partners with pharma company Tolmar - Mobi Health News

Telehealth firm UpScriptHealth partners with pharma company Tolmar Mobi Health News

The pharma& Group Enters into an Exclusive Promotional Agreement with Tolmar, Inc. to Promote Rubraca® (rucaparib) in the U.S. for the Treatment of Metastatic Castration-Resistant Prostate Cancer - PR Newswire

The pharma& Group Enters into an Exclusive Promotional Agreement with Tolmar, Inc. to Promote Rubraca® (rucaparib) in the U.S. for the Treatment of Metastatic Castration-Resistant Prostate Cancer PR Newswire

DelSiTech and Tolmar International Sign Global License & Development Agreement - Contract Pharma

DelSiTech and Tolmar International Sign Global License & Development Agreement Contract Pharma

Prostate Cancer Drug Eligard Available for Palliative Care, Tolmar Says - Bionews

Prostate Cancer Drug Eligard Available for Palliative Care, Tolmar Says Bionews

J&J Wins Ruling Blocking Tolmar’s Copies of Schizophrenia Drug - Bloomberg Law News

J&J Wins Ruling Blocking Tolmar’s Copies of Schizophrenia Drug Bloomberg Law News

How a small suburban pharma company is grabbing sales from AbbVie - Crain's Chicago Business

How a small suburban pharma company is grabbing sales from AbbVie Crain's Chicago Business

Tolmar Announces Results From Inaugural Landmark Survey of US Physicians To Assess Current State of Testosterone Replacement Therapy (TRT) and the Impact on Practices and Patient Care - PR Newswire

Tolmar Announces Results From Inaugural Landmark Survey of US Physicians To Assess Current State of Testosterone Replacement Therapy (TRT) and the Impact on Practices and Patient Care PR Newswire

Tolmar transitions to thermoforms - Packaging World

Tolmar transitions to thermoforms Packaging World

Mundipharma acquires Australia's Tolmar; adds Eligard to its portfolio - BioSpectrum Asia

Mundipharma acquires Australia's Tolmar; adds Eligard to its portfolio BioSpectrum Asia

Tolmar Affirms Full Supply of Eligard® (Leuprolide Acetate) for Injectable Suspension for the Palliative Management of Advanced Prostate Cancer - PR Newswire

Tolmar Affirms Full Supply of Eligard® (Leuprolide Acetate) for Injectable Suspension for the Palliative Management of Advanced Prostate Cancer PR Newswire

Tolmar Pharmaceuticals Sponsors 2018 ZERO - The End of Prostate Cancer Endurance Team at the Bank of America Chicago Marathon - PR Newswire

Tolmar Pharmaceuticals Sponsors 2018 ZERO - The End of Prostate Cancer Endurance Team at the Bank of America Chicago Marathon PR Newswire

TOLMAR Pharmaceuticals Established To Market ELIGARD For Advanced Prostate Cancer In The U.S. And Puerto Rico - PR Newswire

TOLMAR Pharmaceuticals Established To Market ELIGARD For Advanced Prostate Cancer In The U.S. And Puerto Rico PR Newswire

FDA Approves FENSOLVI® (leuprolide acetate) for Injectable Suspension for Pediatric Patients with Central Precocious Puberty - PR Newswire

FDA Approves FENSOLVI® (leuprolide acetate) for Injectable Suspension for Pediatric Patients with Central Precocious Puberty PR Newswire

Tolmar Affirms Supply of FENSOLVI® (leuprolide acetate) for Pediatric Patients with Central Precocious Puberty - PR Newswire

Tolmar Affirms Supply of FENSOLVI® (leuprolide acetate) for Pediatric Patients with Central Precocious Puberty PR Newswire

Top Tolmar Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant